Literature DB >> 23000342

Nemo-like kinase, a multifaceted cell signaling regulator.

Tohru Ishitani1, Shizuka Ishitani.   

Abstract

Nemo-like kinase (NLK) is an evolutionarily conserved MAP kinase-related kinase. Although NLK was originally identified as a Drosophila gene affecting cell movement during eye development, recent studies show that NLK also contributes to cell proliferation, differentiation, and morphological changes during early embryogenesis and nervous system development in vertebrates. In addition, NLK has been reported to be involved in the development of several human cancers. NLK is able to play a role in multiple processes due to its capacity to regulate a diverse array of signaling pathways, including the Wnt/β-catenin, Activin, IL-6, and Notch signaling pathways. Although the molecular mechanisms that regulate NLK activity remain unclear, our recent research has presented a new model for NLK activation. Here, we summarize the current understanding of the function and regulation of NLK and discuss the aspects of NLK regulation that remain to be resolved.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000342     DOI: 10.1016/j.cellsig.2012.09.017

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  29 in total

1.  MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK.

Authors:  Dongling Zou; Dong Wang; Rong Li; Ying Tang; Li Yuan; Xingtao Long; Qi Zhou
Journal:  Tumour Biol       Date:  2015-04-02

2.  Expression of Nemo-like kinase after spinal cord injury in rats.

Authors:  Dawei Xu; Wei Zhao; Gang Pan; Ming Qian; Xinhui Zhu; Wei Liu; Gang Cai; Zhiming Cui
Journal:  J Mol Neurosci       Date:  2014-01-07       Impact factor: 3.444

Review 3.  The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.

Authors:  Ying Huang; Yang Yang; Yong He; Jun Li
Journal:  Tumour Biol       Date:  2015-10-01

4.  Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer.

Authors:  Maolan Li; Shenglai Zhang; Zhiqiang Wang; Bingtai Zhang; Xiangsong Wu; Hao Weng; Qian Ding; Zhujun Tan; Ning Zhang; Jiasheng Mu; Jiahua Yang; Yijun Shu; Runfa Bao; Qichen Ding; Wenguang Wu; Yang Cao; Yingbin Liu
Journal:  Tumour Biol       Date:  2013-07-16

5.  Stabilization of ATF5 by TAK1-Nemo-like kinase critically regulates the interleukin-1β-stimulated C/EBP signaling pathway.

Authors:  Ze-Yan Zhang; Shang-Ze Li; Hui-Hui Zhang; Qu-Ran Wu; Jun Gong; Tong Liang; Lu Gao; Na-Na Xing; Wen-Bin Liu; Run-Lei Du; Xiao-Dong Zhang
Journal:  Mol Cell Biol       Date:  2014-12-15       Impact factor: 4.272

6.  Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.

Authors:  Wei Zhang; Jian He; Yan Du; Xian-Hua Gao; Yan Liu; Qi-Zhi Liu; Wen-Jun Chang; Guang-Wen Cao; Chuan-Gang Fu
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

7.  Nemo-like kinase regulates postnatal skeletal homeostasis.

Authors:  Ernesto Canalis; Lauren Kranz; Stefano Zanotti
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

8.  Expression of Nemo-like kinase was increased and negatively correlated with the expression of TCF4 in lung cancers.

Authors:  Xiu-Wei Zhang; Song-Yan Chen; Dong-Wei Xue; Hui-Hui Xu; Lian-He Yang; Hong-Tao Xu; En-Hua Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  YAP needs Nemo to guide a Hippo.

Authors:  Alexander Hergovich
Journal:  EMBO Rep       Date:  2016-12-15       Impact factor: 8.807

10.  Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington's disease.

Authors:  Mali Jiang; Xiaoyan Zhang; Hongshuai Liu; Jared LeBron; Athanasios Alexandris; Qi Peng; Hao Gu; Fanghan Yang; Yuchen Li; Ruiling Wang; Zhipeng Hou; Nicolas Arbez; Qianwei Ren; Jen-Li Dong; Emma Whela; Ronald Wang; Tamara Ratovitski; Juan C Troncoso; Susumu Mori; Christopher A Ross; Janghoo Lim; Wenzhen Duan
Journal:  Hum Mol Genet       Date:  2020-05-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.